260 related articles for article (PubMed ID: 16086069)
1. [Expressions of PDCD5 and p53 in oral leukoplakia and oral squamous cell carcinoma].
Zhao XY; Liu HW; Wei MJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):429-32. PubMed ID: 16086069
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
Shintani S; Yoshihama Y; Emilio AR; Matsumura T
Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
4. Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma.
Gopalakrishnan R; Weghorst CM; Lehman TA; Calvert RJ; Bijur G; Sabourin CL; Mallery SR; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Apr; 83(4):471-7. PubMed ID: 9127380
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma.
Lin L; Wang J; Liu D; Liu S; Xu H; Ji N; Zhou M; Zeng X; Zhang D; Li J; Chen Q
Sci Rep; 2016 May; 6():26757. PubMed ID: 27225603
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the PRL-3 gene in human oral squamous cell carcinoma and dysplasia tissues.
Hassan NM; Hamada J; Kameyama T; Tada M; Nakagawa K; Yoshida S; Kashiwazaki H; Yamazaki Y; Suzuki Y; Sasaki A; Nagatsuka H; Inoue N; Moriuchi T
Asian Pac J Cancer Prev; 2011; 12(4):947-51. PubMed ID: 21790231
[TBL] [Abstract][Full Text] [Related]
7. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-alpha overexpression in proliferative verrucous leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
Kannan R; Bijur GN; Mallery SR; Beck FM; Sabourin CL; Jewell SD; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jul; 82(1):69-74. PubMed ID: 8843456
[TBL] [Abstract][Full Text] [Related]
10. [Expression and its relationship of murine double minute 2 and P53 protein in oral leukoplakia and squamous cell carcinoma].
Han BF; Wu PF; Pan J; Li Y; Li LJ
Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Feb; 29(1):79-82. PubMed ID: 21427907
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical analysis of the p53 tumor suppressor gene product in oral leukoplakia].
Kikegawa A
Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):51-9. PubMed ID: 11321806
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
14. Use of cytological specimens for p53 gene alteration detection in oral squamous cell carcinoma risk patients.
López M; Aguirre JM; Cuevas N; Anzola M; Videgain J; Aguirregaviria J; Castro A; de Pancorbo MM
Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):366-70. PubMed ID: 15341441
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
Fan GK; Chen J; Ping F; Geng Y
Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
[TBL] [Abstract][Full Text] [Related]
16. p53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa.
Girod SC; Krueger G; Pape HD
Int J Oral Maxillofac Surg; 1993 Oct; 22(5):285-8. PubMed ID: 8245568
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity.
Piattelli A; Rubini C; Fioroni M; Iezzi G; Santinelli A
J Oral Maxillofac Surg; 2002 May; 60(5):532-40. PubMed ID: 11988932
[TBL] [Abstract][Full Text] [Related]
18. Retinoblastoma and p53 protein expression in pre-malignant oral lesions and oral squamous cell carcinoma.
de Oliveira MG; Ramalho LM; Gaião L; Pozza DH; de Mello RA
Mol Med Rep; 2012 Jul; 6(1):163-6. PubMed ID: 22576742
[TBL] [Abstract][Full Text] [Related]
19. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of the programmed cell death 5 gene and protein in laryngeal squamous cell carcinoma.
Xu F; Wu K; Zhao M; Qin Y; Xia M
J Int Med Res; 2013 Dec; 41(6):1838-47. PubMed ID: 24265335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
